To sum up, to our knowledge, the current study firstly provided evidences to certify genetic variants in the RhoA/ROCK1 pathway, especially rs2269736 and combined risk alleles may be promising novel predictors to forecast development, progression and prognosis of prostate cancer. This evidence concerns the gene RHOA and Familial prostate cancer.